Creative Medical Technology (CELZ) News Today → The “Next Bitcoin”? 10 CENT Crypto Set to Explode (From True Market Insiders) (Ad) Free CELZ Stock Alerts $4.32 -0.08 (-1.82%) (As of 04/26/2024 ET) Add Compare Share Share HeadlinesStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial Media All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative SourceHeadlineCreative Medical Technology Holdings Inc CELZmorningstar.com - April 24 at 3:50 AMComparing Zura Bio (NASDAQ:ZURA) & Creative Medical Technology (NASDAQ:CELZ)americanbankingnews.com - April 19 at 1:52 AMCreative Medical Technology Holdings Full Year 2023 Earnings: Revenues Beat Expectations, EPS Lagsfinance.yahoo.com - March 24 at 3:36 PMMedical Practices And Branding In A Digital Ageforbes.com - March 18 at 9:29 AMCreative Medical Technology Skyrockets on Word of New Diabetes Medicationtheglobeandmail.com - March 18 at 9:29 AMWhy Is Diabetes Focused Creative Medical Stock Surging On Thursday?msn.com - March 7 at 7:32 PMCreative Medical Announces FDA Authorization For Expanded Access For CELZ-201; Stock Upmarkets.businessinsider.com - March 7 at 1:13 PMCreative Medical Shares Rise 37% After FDA Authorization for CELZ-201marketwatch.com - March 7 at 1:13 PMCreative Medical stock rallies for second day on FDA updatesmsn.com - March 7 at 1:13 PMCreative Medical Technology Holdings Inc. Announces FDA Authorization for Groundbreaking Type 1 Diabetes Prevention Therapy Under Expanded Accessfinance.yahoo.com - March 7 at 1:13 PMmarketbeat.com - March 7 at 9:46 AMmarketbeat.com - March 7 at 9:35 AMCreative Medical Technology Holdings Incmorningstar.com - March 6 at 5:13 PMCreative Medical Receives FDA Orphan Drug Designation For CELZ-101; Stock Up In Pre-marketmarkets.businessinsider.com - March 6 at 5:13 PMCreative Medical Shares Rally Premarket on FDA Orphan Designationmarketwatch.com - March 6 at 5:13 PMCreative Medical stock rallies 18% on FDA orphan drug designationmsn.com - March 6 at 5:13 PMmarketbeat.com - March 6 at 12:11 PMCreative Medical Technology Holdings, Inc. Receives FDA Orphan Drug Designation for CELZ-101 in Key Transplantation Therapybusinesswire.com - March 6 at 7:00 AMCreative Medical Technology Holdings Inc (CELZ)investing.com - February 15 at 12:52 AMSteven L White's Net Worthbenzinga.com - February 9 at 7:42 AMmarketbeat.com - December 20 at 10:18 AMCreative Medical Technology Holdings (NASDAQ:CELZ) Granted FDA Clearance To Begin Phase 1/2 Clinical Trial Of AlloStem(TM) For Addressing Chronic Lower Back Painfinance.yahoo.com - December 20 at 9:45 AMmarketbeat.com - December 20 at 9:40 AMCreative Medical to initiate trial of lower back pain treatmentmsn.com - October 11 at 2:17 PMCreative Medical Gets IRB Approval For StemSpine Trial Using AlloStem Cell Therapymarkets.businessinsider.com - October 10 at 9:28 AMCreative Medical Technology Holdings Announces IRB Approval for FDA Cleared Phase 1/2 Clinical Trial of StemSpine® using AlloStem™ ("CELZ-201-DDT") Novel Cell Therapy to Treat Chronic Lower Back Painfinance.yahoo.com - October 10 at 9:28 AMWhat Makes Creative Medical Technology Holdings, Inc. (CELZ) a New Buy Stockfinance.yahoo.com - September 22 at 3:36 PMCreative Medical Technology Holdings Receives FDA Clearance to Initiate a Phase 1/2 Clinical Trial of StemSpine® using AlloStem™ (CELZ-201-DDT) for the Treatment of Chronic Lower Back Painfinance.yahoo.com - September 19 at 8:35 AMWhat Is Allogeneic Cell Therapy, And What’s Driving This Market’s 25%+ Annual Global Growth?finance.yahoo.com - August 24 at 5:29 PMWhat Is Allogeneic Cell Therapy, And What's Driving This Market's 25%+ Annual Global Growth?benzinga.com - August 23 at 10:48 AMCreative Medical Technology regains Nasdaq listing compliancemsn.com - June 28 at 9:02 AMCreative Medical Technology Holdings Provides Corporate Updatefinance.yahoo.com - June 12 at 4:21 PMCreative Medical Technology Announces $2 Million Share Repurchase Programfinance.yahoo.com - June 12 at 4:21 PMCreative Medical Technology Holdings announces reverse stock split to regain compliancemsn.com - June 9 at 3:36 PMCreative Medical Technology Holdings Announces Successful Completion of the First Phase of its Program with Greenstone Biosciences, Inc. to Develop Next Generation iPSC Pipeline for ImmCelz® Immunotherapy Platformfinance.yahoo.com - May 31 at 9:44 AMCreative Medical Releases Data From StemSpine Procedure For Chronic Lower Back Painmsn.com - May 18 at 4:09 PMCreative Medical Technology Holdings Announces Positive Top-Line Study Results for Chronic Lower Back Pain Utilizing its StemSpine® Procedure Using AlloStem™ Allogenic Cell Linefinance.yahoo.com - May 18 at 4:09 PMCreative Medical Technology Holdings First Quarter 2023 Earnings: US$0.075 loss per share (vs US$0.18 loss in 1Q 2022)finance.yahoo.com - May 14 at 10:03 AMCreative Medical (CELZ) Up 86% on Upbeat Diabetes Study Datamsn.com - April 13 at 6:09 PMCreative Medical Technology Soars after Positive Drug Datamsn.com - April 12 at 3:53 PMThinking about buying stock in Newmark Group, Exscientia, Pardes Biosciences, Creative Medical Technology, or Somalogic?benzinga.com - April 12 at 10:53 AMWhy Is Creative Medical Technology Stock Skyrocketing Today?msn.com - April 12 at 10:53 AMmarketbeat.com - April 12 at 10:49 AMCreative Medical Technology Holdings Announces Filing of 2022 Form 10-K and Provides Business Updatefinance.yahoo.com - April 4 at 10:24 AMCreative Medical stock rises on seeking FDA orphan drug status for Brittle diabetes therapymsn.com - March 23 at 2:54 PMCreative Medical Technology Files Orphan Drug Designation Application with the U.S. FDA Using the ImmCelz® Platform for the Treatment of Brittle Type 1 Diabetesfinance.yahoo.com - March 23 at 9:53 AMCreative Medical Technology Holdings Announces Key Milestones Regarding ImmCelz® Platform Developmentfinance.yahoo.com - March 21 at 12:44 PMCreative Medical Technology Holdings Engages Highly Respected International CRO for Phase 1 / 2 Clinical Trial to Treat Type 1 Diabetes Using CELZ-201finance.yahoo.com - March 7 at 10:37 AMThree Year Follow-Up Results Confirm Efficacy of StemSpine® Procedure for Treating Chronic Lower Back Pain, with No Serious Adverse Effectsfinance.yahoo.com - February 14 at 12:45 PMThinking about buying stock in Creative Medical, Meta, Advanced Micro Devices, Carvana, or SeqLL?benzinga.com - February 8 at 1:17 PM Get Creative Medical Technology News Delivered to You Automatically Sign up to receive the latest news and ratings for CELZ and its competitors with MarketBeat's FREE daily newsletter. Email Address Forget AI, Imperium Is Expected to Grow 320,00% in 3 Years (Ad)If you think AI is big, then you have got to check out something I call Imperium… By my calculations, it’s set to grow 320,000% in three years. (You can see my calculations here.) Watch my video for all of the details CELZ Media Mentions By Week CELZ Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. CELZ News Sentiment▼0.500.33▲Average Medical News Sentiment CELZ News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. CELZ Articles This Week▼20▲CELZ Articles Average Week Get Creative Medical Technology News Delivered to You Automatically Sign up to receive the latest news and ratings for CELZ and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: Titan Pharmaceuticals News Fresh Tracks Therapeutics News Gamida Cell News TRACON Pharmaceuticals News Genetic Technologies News Palisade Bio News Finch Therapeutics Group News BioCardia News Avalon GloboCare News Kiromic BioPharma News Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:CELZ) was last updated on 4/28/2024 by MarketBeat.com Staff From Our PartnersConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsThe Best AI Stock to Own in the World Today is Trading for Just $25Banyan Hill PublishingThis AI Trade Machine Made 1,729%* (With 89% Wins)Prosper Trading AcademyHis win rate puts Warren Buffett to shame… Investing DailyDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsThe A.I. story nobody is telling you (Read ASAP)TradeSmithBitcoin Rockets To Record High But Buy THIS InsteadParadigm Press4 Cryptos BETTER than BitcoinTrue Market Insiders Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Creative Medical Technology Holdings, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
